Norden Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$643K Buy
+1,662
New +$616K 0.05% 301
2026
Q1
Sell
-805
Closed -$282K 640
2025
Q4
$282K Buy
+805
New +$272K 0.03% 485
2024
Q4
Sell
-478
Closed -$249K 536
2024
Q3
$249K Sell
478
-7
-1% -$3.74K 0.03% 443
2024
Q2
$263K Buy
485
+47
+11% +$24.8K 0.05% 338
2024
Q1
$227K Buy
+438
New +$218K 0.05% 371

Other funds holding ELV

Norden Group's ELV Position: Q2 2026 in Review

Norden Group opened a new position in Elevance Health (ELV) in Q2 2026: 1,662 shares worth $643K. The stake represents 0.05% of the portfolio and ranks #301 among its holdings. This is a return to the name: Norden Group previously reported a position in ELV as recently as Q4 2025.

Norden Group first reported a position in ELV in Q1 2024 and has held it in 5 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Norden Group held 1,662 shares of Elevance Health worth $643K as of Q2 2026.
  • Elevance Health was a new Norden Group position in Q2 2026.
  • Elevance Health made up 0.05% of Norden Group's portfolio in Q2 2026, its #301 holding.
  • Norden Group first reported a position in Elevance Health in Q1 2024 and has held it in 5 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.